LYKALABSNSELyka Labs Limited· PharmaceuticalsMediumNeutral
Announced Fri, 11 Jul · 10:45 IST

Lyka Labs Limited has informed the Exchange about General Updates

Regulatory & Legal View source PDF

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lyka Labs Limited informed the exchanges that the NCLT Ahmedabad hearing on its Scheme of Amalgamation with Lyka Exports Limited (Transferor Company) could not take place on 10th July 2025 due to technical difficulties (AC failure and infrastructure issues at the tribunal). As per the NCLT order, the matter has been adjourned and re-listed for hearing on 7th August 2025. Lyka Labs is the Transferee Company in this proposed merger under Sections 230-232 of the Companies Act, 2013. The petition was originally filed in 2024 and has been pending consideration.

Likely market impact

This is a routine procedural adjournment with no material impact on the company's operations or the merger's prospects. Shareholders should note that the amalgamation remains pending NCLT approval, and the next key date to watch is 7th August 2025.